related documents
- EFFECT OF FONDAPARINUX 2.5 MG ONCE DAILY ON ALL CAUSE MORTALITY: A META-ANALYSIS OF THROMBOPROPHYLAXIS TRIALS Conferences
- PERIOPERATIVE MANAGEMENT OF ANTICOAGULATION WITH TAPERED DOSE WARFARIN Conferences
- PHARMACOKINETICS (PK) OF SUBCUTANEOUS FONDAPARINUX 1.5 MG IN PATIENTS WITH MODERATE RENAL IMPAIREMENT (MRI) Conferences